Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pretet

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Revue Francaise Des Maladies Respiratoires|January 1, 1983
[Short-term chemotherapy of tuberculosis. Cooperative French trial]S Pretet
Revue Francaise Des Maladies Respiratoires|January 1, 1980
[Toxicity of pyrazinamide in antituberculous treatments (author's transl)]S Pretet, S Perdrizet
Revue De Tuberculose Et De Pneumologie|April 1, 1970
[Survival of tuberculous bacilli in combined treatments including rifampicin]B Kreis, S Pretet
Revue De Pneumologie Clinique|January 1, 1994
[Symptomatology of tuberculosis]S Pretet, M Sansonetti
Revue Des Maladies Respiratoires|January 1, 1988
[Critical study of the indications for long-term oxygen therapy. Chronic obstructive bronchopneumopathies]P Sadoul, H Duwoos, S Pretet
Revue De Pneumologie Clinique|January 1, 1996
[From first symptom to diagnosis and from diagnosis to treatment of tuberculosis: still a long delay]Z Gulbaran, S Pretet, D Dusser
Presse Medicale (Paris, France : 1983)|March 26, 1983
[Value of pyrazinamide in the short-term treatment of tuberculosis]S Pretet, J Marsac, D Choudat
Bulletin of the International Union Against Tuberculosis|December 1, 1978
[Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)]S Pretet, J Grosset, S Perdrizet
Bulletin of the International Union Against Tuberculosis|June 1, 1970
[Survey on the results of routine treatment of 1,199 pulmonary tuberculosis patients treated for the 1st time]E Bernard, O Abadi, S Pretet
Lancet (London, England)|February 13, 1982
Pyrazinamide is a major antituberculosis drugS Pretet, R Liard, S Perdrizet
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Revue Francaise Des Maladies Respiratoires|January 1, 1983
[Short-term chemotherapy of tuberculosis. Cooperative French trial]S Pretet
Revue Francaise Des Maladies Respiratoires|January 1, 1980
[Toxicity of pyrazinamide in antituberculous treatments (author's transl)]S Pretet, S Perdrizet
Revue De Tuberculose Et De Pneumologie|April 1, 1970
[Survival of tuberculous bacilli in combined treatments including rifampicin]B Kreis, S Pretet
Revue De Pneumologie Clinique|January 1, 1994
[Symptomatology of tuberculosis]S Pretet, M Sansonetti
Revue Des Maladies Respiratoires|January 1, 1988
[Critical study of the indications for long-term oxygen therapy. Chronic obstructive bronchopneumopathies]P Sadoul, H Duwoos, S Pretet
Revue De Pneumologie Clinique|January 1, 1996
[From first symptom to diagnosis and from diagnosis to treatment of tuberculosis: still a long delay]Z Gulbaran, S Pretet, D Dusser
Presse Medicale (Paris, France : 1983)|March 26, 1983
[Value of pyrazinamide in the short-term treatment of tuberculosis]S Pretet, J Marsac, D Choudat
Bulletin of the International Union Against Tuberculosis|December 1, 1978
[Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)]S Pretet, J Grosset, S Perdrizet
Bulletin of the International Union Against Tuberculosis|June 1, 1970
[Survey on the results of routine treatment of 1,199 pulmonary tuberculosis patients treated for the 1st time]E Bernard, O Abadi, S Pretet
Lancet (London, England)|February 13, 1982
Pyrazinamide is a major antituberculosis drugS Pretet, R Liard, S Perdrizet
Pageof 4